Trisenox Market Overview 2030:
Trisenox, also commonly known as arsenic trioxide, is an anti-cancer chemotherapy drug that is used to treat acute promyelocytic leukemia. It is a disease in which the bone marrow contains an abnormally high number of immature blood cells. The drug is administered intravenously, with the dose varying from patient to patient based on body mass index and overall body metabolism. The drug is widely used as and when other chemotherapy treatments have failed to produce positive results on the patient’s body. Few of the side effects associated with the medication include rapid heartbeat, nausea, black stools, and increased fatigue.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with the governments around the globe are working to address the COVID-19 outbreak, from supporting the vaccines development to medicine supply chain planning. Approximately around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a significant increase in demand for the treatment of COVID-19. Such increased demand for these drugs has presented huge opportunities for manufacturers of COVID-19 treatment drugs, as many developed countries are experiencing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future due to the demand for vaccine and the treatment medicines for COVID-19. This is expected to have a significant impact on the trisenox market.
Top Impacting Factors
- Rise in cancer cases around the globe along with increase in demand for chemotherapy are expected to drive the growth of trisenox market. The medication is primarily used in the treatment of acute promyelocytic leukemia.
- COVID-19 and its subsequent side effects on the body have raised concerns against rise in incidents of cancer and related chronic diseases thus resulting in huge influx of investments from both public and private sector for the treatment of the above mentioned diseases.
- The general pharmacological shift toward the discovery of advanced therapeutic products capable of incorporating advanced technological solutions is also expected to drive the growth of the trisenox market.
- However, the side effects associated with chemotherapy such as nausea, vomiting, and mouth sores. along with lack of awareness in underdeveloped regions is likely to affect the market growth for trisenox.
- Furthermore, high design, development, and delivery costs associated with the medication are likely to limit the market penetration into populations with lower purchasing power parity.
Key Market Trends
- North America is anticipated to dominate the market owing to rise in cases of cancer along with the surge in demand for advanced new -age medication alternatives to provide instant relief efficacy.
- Recently, , high levels of arsenic oxide were discovered in Lucknow, Uttar Pradesh with the highest contamination reaching 250ppb in Gokula village and Gosain Purva, despite the fact that the acceptable limit of trisenox in these areas is only 10ppb.
- Scientists at IIT Guwahati are developing a technology to remove arsenic trioxide from drinking water . They have created various prototypes for purifying the water from arsenic trioxide contamination using nanotechnology and electrocoagulation techniques..
- Teva Ltd. announced in 2019 that a trisenox injection had been thoroughly approved by the U.S. Food and Drug Administration (USFDA). The injection is being used in combination with tretinoin for the treatment of patients suffering from acute promyelocytic leukemia.
- The European Medical Agency (EMA) has warned against approving a 2mg/ml trisenox injection in addition to the existing 1mg/ml dose present in each vial. The agency concerned about the presence of the 2 similar concentrations in the market is expected to lead to medical and technical errors. In addition, there are concerns about an overdose which could potentially lead to hemorrhages and cardiac arrests in some cases.
- A similar medication was also launched by Cell Therapeutics and Fresenius Kabi for consolidation in patients suffering from promyelocytic leukemia.
Key Benefits of the Report
- This study presents the analytical depiction of the trisenox industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the trisenox market share.
- The current market is quantitatively analyzed to highlight the growth scenario of the trisenox market.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and the competition that will take shape in the coming years.
Questions Answered in the Trisenox Report
- Who are the leading market players active in the trisenox market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the trisenox market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What are the future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 on the industry?
- What is trisenox?
- What is the prediction of the trisenox market in the future?
- What are the current and predicted trends?
Trisenox Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Goyal Chem Associates, SAE Manufacturing Specialties Corp, Teva Pharmaceutical, Seidler Chemical Company, Reagents LLC, Amring Pharmaceuticals, Fresenius Kabi, Nexus Pharmaceuticals, Cell Therapeutics, All-Chemie, Ltd. |
Loading Table Of Content...
